136 related articles for article (PubMed ID: 31837368)
21. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
22. Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo.
Beshbishy AM; Batiha GE; Yokoyama N; Igarashi I
Parasit Vectors; 2019 May; 12(1):269. PubMed ID: 31138282
[TBL] [Abstract][Full Text] [Related]
23. Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Chen HS; Bai MH; Zhang T; Li GD; Liu M
Int J Oncol; 2015 Apr; 46(4):1730-8. PubMed ID: 25647396
[TBL] [Abstract][Full Text] [Related]
24. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
25. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional sharp pH-responsive nanoparticles for targeted drug delivery and effective breast cancer therapy.
Yao Y; Saw PE; Nie Y; Wong PP; Jiang L; Ye X; Chen J; Ding T; Xu L; Yao H; Hu H; Xu X
J Mater Chem B; 2019 Jan; 7(4):576-585. PubMed ID: 32254791
[TBL] [Abstract][Full Text] [Related]
27. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
28. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
30. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
31. pH-responsive hybrid magnetic polyelectrolyte complex based on alginate/BSA as efficient nanocarrier for curcumin encapsulation and delivery.
Amani S; Mohamadnia Z; Mahdavi A
Int J Biol Macromol; 2019 Dec; 141():1258-1270. PubMed ID: 31518625
[TBL] [Abstract][Full Text] [Related]
32. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
34. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
Ma Y; Coombes AG
J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007
[TBL] [Abstract][Full Text] [Related]
35. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
36. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
Gunduz U; Keskin T; Tansık G; Mutlu P; Yalcin S; Unsoy G; Yakar A; Khodadust R; Gunduz G
Biomed Pharmacother; 2014 Jul; 68(6):729-36. PubMed ID: 25194441
[TBL] [Abstract][Full Text] [Related]
37. Preparation of biocompatible copolymeric micelles as a carrier of atorvastatin and rosuvastatin for potential anticancer activity study.
Hamidreza Kheiri M; Alimohammadi N; Danafar H
Pharm Dev Technol; 2019 Mar; 24(3):303-313. PubMed ID: 29741465
[TBL] [Abstract][Full Text] [Related]
38. Enhanced susceptibility to apoptosis and growth arrest of human breast carcinoma cells treated with silica nanoparticles loaded with monohydroxy flavone compounds.
Abo El-Maali N; Badr G; Sayed D; Adam R; Abd El Wahab G
Biochem Cell Biol; 2019 Oct; 97(5):513-525. PubMed ID: 30640511
[TBL] [Abstract][Full Text] [Related]
39. The Anticancer Activity of Complex [Cu2(μ-(C6H5)2CHCOO)3(bipy)2)] (ClO4) -Solid Lipid Nanoparticles on MCF-7 Cells.
Kani I; Dikmen G; Eskiler GG; Cecener G; Tunca B; Egeli U
Curr Drug Deliv; 2016; 13(8):1339-1350. PubMed ID: 26750100
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of schizophyllan nanogels via inverse emulsion using biobased materials.
Mousaviasl S; Saleh T; Shojaosadati SA; Boddohi S
Int J Biol Macromol; 2018 Dec; 120(Pt A):468-474. PubMed ID: 30153460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
